 | • レポートコード：MRC2204A200 • 出版社/出版日：Transparency Market Research / 2022年1月 • レポート形態：英文、PDF、179ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の本調査レポートは、世界のトリクラベンダゾール市場について調査し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、主要インサイト、剤形別（錠剤、経口懸濁液）分析、動物種類別分析、流通チャネル別分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況などを掲載しています。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・主要インサイト ・世界のトリクラベンダゾール市場規模：剤形別（錠剤、経口懸濁液） ・世界のトリクラベンダゾール市場規模：動物種類別 ・世界のトリクラベンダゾール市場規模：流通チャネル別 ・世界のトリクラベンダゾール市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ） ・競争状況 |
Triclabendazole Market – Scope of Report
TMR’s report on the global triclabendazole market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides revenue of the global triclabendazole market for the period 2017–2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global triclabendazole market from 2021 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the triclabendazole market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global triclabendazole market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global triclabendazole market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global triclabendazole market.
The report delves into the competitive landscape of the global triclabendazole market. Key players operating in the global triclabendazole market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global triclabendazole market profiled in this report.
Key Questions Answered in Triclabendazole Market Report
What is the sales/revenue generated by triclabendazole across all regions during the forecast period?
What are the opportunities in the global triclabendazole market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2031?
Which segment is likely to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?
Triclabendazole Market – Research Objectives and Research Approach
The comprehensive report on the global triclabendazole market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global triclabendazole market in terms of dosage form, animal type, distribution channel, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global triclabendazole market.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Triclabendazole Market
4. Market Overview
4.1. Introduction
4.1.1. Market Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Triclabendazole Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Prevalence rate of Fasciola hepatica in animal health
5.2. Sales Volume of Triclabendazole (Best effort Basis)
5.3. Pricing Analysis
5.4. Regulatory Scenario by Region/globally
5.5. COVID-19 Impact Analysis
6. Global Triclabendazole Market Analysis and Forecast, by Dosage Form
6.1. Introduction & Definition
6.1.1. Key Findings / Developments
6.2. Global Triclabendazole Market Value Forecast, by Dosage Form, 2017–2031
6.2.1. Tablet
6.2.2. Oral Suspension
6.3. Global Triclabendazole Market Attractiveness, by Dosage Form
7. Global Triclabendazole Market Analysis and Forecast, by Animal Type
7.1. Introduction & Definition
7.1.1. Key Findings / Developments
7.2. Global Triclabendazole Market Value Forecast, by Animal Type, 2017–2031
7.2.1. Cattle
7.2.2. Sheep
7.2.3. Goat
7.2.4. Others
7.3. Global Triclabendazole Market Attractiveness, by Animal Type
8. Global Triclabendazole Market Analysis and Forecast, by Distribution Channel
8.1. Introduction & Definition
8.1.1. Key Findings / Developments
8.2. Global Triclabendazole Market Value Forecast, by Distribution Channel, 2017–2031
8.2.1. Veterinary Hospitals
8.2.2. Veterinary Clinics
8.2.3. Pharmacies & Drug Stores
8.2.4. Others
8.3. Global Triclabendazole Market Attractiveness, by Distribution Channel
9. Global Triclabendazole Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Global Triclabendazole Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. North America Triclabendazole Market Attractiveness, by Region
10. North America Triclabendazole Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. North America Triclabendazole Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2031
10.2.1. Tablet
10.2.2. Oral Suspension
10.3. North America Triclabendazole Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031
10.3.1. Cattle
10.3.2. Sheep
10.3.3. Goat
10.3.4. Others
10.4. North America Triclabendazole Market Value Forecast, by Distribution Channel, 2017–2031
10.4.1. Veterinary Hospitals
10.4.2. Veterinary Clinics
10.4.3. Pharmacies & Drug Stores
10.4.4. Others
10.4.5. North America Triclabendazole Market Attractiveness, by Distribution Channel
10.5. North America Triclabendazole Market Value (US$ Mn) Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. North America Triclabendazole Market Attractiveness Analysis
10.6.1. By Dosage Form
10.6.2. By Animal Type
10.6.3. By Distribution Channel
10.6.4. By Country
11. Europe Triclabendazole Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Europe Triclabendazole Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2031
11.2.1. Tablet
11.2.2. Oral Suspension
11.3. Europe Triclabendazole Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031
11.3.1. Cattle
11.3.2. Sheep
11.3.3. Goat
11.3.4. Others
11.4. Europe Triclabendazole Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
11.4.1. Germany
11.4.2. U.K.
11.4.3. France
11.4.4. Spain
11.4.5. Italy
11.4.6. Rest of Europe
11.5. Europe Triclabendazole Market Attractiveness Analysis
11.5.1. By Dosage Form
11.5.2. By Animal Type
11.5.3. By Distribution Channel
11.5.4. By Country/Sub-region
12. Asia Pacific Triclabendazole Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Asia Pacific Triclabendazole Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2031
12.2.1. Tablet
12.2.2. Oral Suspension
12.3. Asia Pacific Triclabendazole Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031
12.3.1. Cattle
12.3.2. Sheep
12.3.3. Goat
12.3.4. Others
12.4. Asia Pacific Triclabendazole Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
12.4.1. China
12.4.2. Japan
12.4.3. India
12.4.4. Australia & New Zealand
12.4.5. Rest of Asia Pacific
12.5. Asia Pacific Triclabendazole Market Attractiveness Analysis
12.5.1. By Dosage Form
12.5.2. By Animal Type
12.5.3. By Distribution Channel
12.5.4. By Country/Sub-region
13. Latin America Triclabendazole Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Latin America Triclabendazole Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2031
13.2.1. Tablet
13.2.2. Oral Suspension
13.3. Latin America Triclabendazole Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031
13.3.1. Cattle
13.3.2. Sheep
13.3.3. Goat
13.3.4. Others
13.4. Latin America Triclabendazole Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
13.4.1. Brazil
13.4.2. Mexico
13.4.3. Rest of Latin America Latin America
13.5. Latin America Triclabendazole Market Attractiveness Analysis
13.5.1. By Dosage Form
13.5.2. By Animal Type
13.5.3. By Distribution Channel
13.5.4. By Country/Sub-region
14. Middle East & Africa Triclabendazole Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Middle East & Africa Triclabendazole Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2031
14.2.1. Tablet
14.2.2. Oral Suspension
14.3. Middle East & Africa Triclabendazole Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031
14.3.1. Cattle
14.3.2. Sheep
14.3.3. Goat
14.3.4. Others
14.4. Middle East & Africa Triclabendazole Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
14.4.1. GCC Countries
14.4.2. South Africa
14.4.3. Rest of Middle East & Africa
14.5. Middle East & Africa Triclabendazole Market Attractiveness Analysis
14.5.1. By Dosage Form
14.5.2. By Animal Type
14.5.3. By Distribution Channel
14.5.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (by Tier and Size of companies)
15.2. Market Share / Position Analysis, by Company, 2020
15.3. Competitive Business Strategies
15.4. Company Profiles
15.4.1. AdvaCare Pharma
15.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.1.2. Financial Analysis
15.4.1.3. Growth Strategies
15.4.1.4. SWOT Analysis
15.4.2. RV Lifesciences Limited
15.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.2.2. Financial Analysis
15.4.2.3. Growth Strategies
15.4.2.4. SWOT Analysis
15.4.3. Grampus Laboratories
15.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.3.2. Financial Analysis
15.4.3.3. Growth Strategies
15.4.3.4. SWOT Analysis
15.4.4. Intas Pharmaceuticals Ltd
15.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.4.2. Financial Analysis
15.4.4.3. Growth Strategies
15.4.4.4. SWOT Analysis
15.4.5. Shanghai Tongren Pharmaceutical Co., Ltd.
15.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.5.2. Financial Analysis
15.4.5.3. Growth Strategies
15.4.5.4. SWOT Analysis
15.4.6. Shijiazhuang Shimu Animal Pharmaceutical Co., Ltd.
15.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.6.2. Financial Analysis
15.4.6.3. Growth Strategies
15.4.6.4. SWOT Analysis
15.4.7. Siflon Drugs & Pharmaceuticals Pvt. Ltd.
15.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.7.2. Financial Analysis
15.4.7.3. Growth Strategies
15.4.7.4. SWOT Analysis
15.4.8. Elanco
15.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.8.2. Financial Analysis
15.4.8.3. Growth Strategies
15.4.8.4. SWOT Analysis
15.4.9. Virbac
15.4.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.9.2. Financial Analysis
15.4.9.3. Growth Strategies
15.4.9.4. SWOT Analysis
15.4.10. Bimeda, Inc.
15.4.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.10.2. Financial Analysis
15.4.10.3. Growth Strategies
15.4.10.4. SWOT Analysis
15.4.11. Chanelle Pharma
15.4.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.11.2. Financial Analysis
15.4.11.3. Growth Strategies
15.4.11.4. SWOT Analysis
15.4.12. Zoetis Health
15.4.12.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.12.2. Financial Analysis
15.4.12.3. Growth Strategies
15.4.12.4. SWOT Analysis
Table 01: Global Triclabendazole Market Volume (000 Unit) Forecast, by Oral Suspension, 2017–2031
Table 02: Global Triclabendazole Market Volume (000 Unit) Forecast, by Tablet, 2017–2031
Table 03: Global Triclabendazole Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2031
Table 04: Global Triclabendazole Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031
Table 05: Global Triclabendazole Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 06: Global Triclabendazole Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 07: North America Triclabendazole Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 08: North America Triclabendazole Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2031
Table 09: North America Triclabendazole Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031
Table 10: North America Triclabendazole Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 11: Europe Triclabendazole Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 12: Europe Triclabendazole Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2031
Table 13: Europe Triclabendazole Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031
Table 14: Europe Triclabendazole Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 15: Asia Pacific Triclabendazole Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 16: Asia Pacific Triclabendazole Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2031
Table 17: Asia Pacific Triclabendazole Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031
Table 18: Asia Pacific Triclabendazole Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 19: Latin America Triclabendazole Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 20: Latin America Triclabendazole Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2031
Table 21: Latin America Triclabendazole Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031
Table 22: Latin America Triclabendazole Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 23: Middle East & Africa Triclabendazole Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 24: Middle East & Africa Triclabendazole Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2031
Table 25: Middle East & Africa Triclabendazole Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031
Table 26: Middle East & Africa Triclabendazole Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031